Tradestie Institutional Equity Comparison Engine

SNDX vs NUVB โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NUVB Overall Edge

NUVB Captures Institutional Edge (3โ€“0 Pillars ยท 6โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Nuvation Bio Inc. (NUVB) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, SNDX trades at N/M Forward P/E with -61.7% operating margin (+81.6% YoY revenue) versus NUVB at N/M Forward P/E and -61.2% operating margin (+242.6% YoY). In options structure, SNDX sits in BREAKDOWN (41st %ile IV; Dealer Gamma Walls on Pro) against NUVB sits in BREAKDOWN (26th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
SNDX N/M vs NUVB N/M Fwd P/E
Growth & Margin Winner NUVB
Op Margin -61.7% vs -61.2% ยท YoY +81.6% vs +242.6%
Momentum & Technical Winner NUVB
1Y -47.8% vs -46.9% ยท 52W Pos 2% vs 2%
Options & Structure Winner NUVB
BREAKDOWN (41st %ile IV) vs BREAKDOWN (26th %ile IV)
SNDX NASDAQ
Syndax Pharmaceuticals, Inc.
Pharmaceutical Preparations
$8.72
-4.49% 1D
Market Cap $822.0M
1M Return -35.74%
1Y Return -47.82%
Forward P/E N/M
Unified AI Score
63.9 / 100 BUY
Tech 60.0 Fund 61.0 Flow 67.0 Mom 55.0
NUVB NYSE
Nuvation Bio Inc.
Pharmaceutical Preparations
$3.80
-0.26% 1D
Market Cap $1.3B
1M Return -19.15%
1Y Return -46.85%
Forward P/E N/M
Unified AI Score
61.0 / 100 BUY
Tech 53.0 Fund 61.0 Flow 67.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SNDX -47.82% NUVB -46.85% Spread: +0.97 pp (NUVB Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period SNDX Revenue NUVB Revenue SNDX Op. Margin NUVB Op. Margin Margin Edge
FY2016 $0M N/A -3587.4% N/A SNDX
FY2017 $0M N/A -2939.0% N/A SNDX
FY2018 $0M N/A -5001.7% N/A SNDX
FY2019 $0M N/A -3792.9% N/A SNDX
FY2020 $0M N/A -4708.2% N/A SNDX
FY2021 $140M N/A 18.8% N/A SNDX
FY2024 $20M $10M -1434.4% -7527.3% SNDX
FY2025 $170M $60M -158.4% -338.7% SNDX

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SNDX (1) vs NUVB (6)
Institutional Metric SNDX NUVB Criterion Row Winner
Market Capitalization Scale $822.0M $1.3B Larger Scale NUVB
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +81.6% +242.6% Higher Growth NUVB
Operating Margin (TTM) Profitability -61.7% -61.2% Higher Margin NUVB
Net Profit Margin Profitability -72.3% -67.4% Higher Margin NUVB
Return on Equity (ROE) Capital Efficiency -426.4% -49.1% Higher ROE NUVB
52-Week Range Position Momentum 2% ($8โ€“$26) 2% ($4โ€“$10) Stronger Trend Tie
Beta / 30D Volatility Risk Regime 0.59ฮฒ ยท 112% Vol 1.52ฮฒ ยท 55% Vol Lower Realized Risk NUVB
Unified Institutional Score Composite Signal 63.9 / 100 (BUY) 61.0 / 100 (BUY) Higher Composite SNDX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SNDX vs NUVB Buy Guide
SNDX BREAKDOWN
95d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 41st %ile
IV Regime Balanced (25thโ€“60th %ile)
Live SNDX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NUVB BREAKDOWN
105d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 26th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live NUVB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SNDX nor NUVB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.